ACTG STUDY IN AIDS--2'3'DIDEOXYINOSINE & AZT FOR AIDS/ARC PATIENTS ON AZT THERAPY

ACTG在艾滋病中的研究--23双脱氧肌苷

• 批准号: 3884547
• 负责人: MICHAEL M LEDERMAN
• 金额: --
• 依托单位: UNIVERSITY HOSPITALS OF CLEVELAND
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3884547
• 关键词: AIDS; AIDS therapy; antiAIDS agent; clinical trials; drug adverse effect; human subject; human therapy evaluation; inosine; nucleotide analog; zidovudine

To compare the efficacy and toxicity of 2', 3' -dideoxyinosine (DDI, BMY- 40900) and zidovudine in patients with AIDS or advanced ARC who have tolerated zidovudine therapy for twelve months or longer.

比较2',3' -二脱氧肌苷(DDI, BMY-